Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

46.40
Delayed Data
As of 4:01pm ET
 +0.50 / +1.09%
Today’s Change
36.81
Today|||52-Week Range
46.49
+14.74%
Year-to-Date
Lilly (LLY) Tops Q1 Earnings, Misses Sales, Shares Down
11:56am / Zacks.com - Paid Partner Content
Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?
Apr 20 / Zacks.com - Paid Partner Content
K-Mart to Sell Cheaper EpiPen Alternative
9:45am / TheStreet.com - Paid Partner Content
Sanofi Epilepsy Drug Responsible for Birth Defects in 4,100 Children, French Regulato...
Apr 20 / TheStreet.com - Paid Partner Content
Sanofi Sues Mylan Over EpiPen Practices
Apr 24 / TheStreet.com - Paid Partner Content
Is J&J's Pharma Sales Slowdown a Warning for Other Players?
Apr 19 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL
Apr 21 / Zacks.com - Paid Partner Content
After Johnson & Johnson Earnings, Buy These Pharma Stocks
Apr 18 / Zacks.com - Paid Partner Content
What to Expect From European Pharmaceuticals' First Quarter Results
Apr 21 / TheStreet.com - Paid Partner Content
Did Pharma & Biotech M&As Pick Pace in Q1?
Apr 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close45.90
Today’s open46.43
Day’s range46.19 - 46.49
Volume1,567,444
Average volume (3 months)1,712,299
Market cap$118.1B
Dividend yield3.40%
Data as of 4:01pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+11.60%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-2.08%
P/E ratio27.4
Price/Sales2.81
Price/Book1.90

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.44+0.68%
GSKGlaxoSmithKline+0.36+0.88%
CELGCelgene+2.37+1.92%
LLYEli Lilly and Co-2.22-2.66%
Data as of 4:03pm ET, 04/25/2017

Financials

Next reporting dateApril 28, 2017
EPS forecast (this quarter)$0.68
Annual revenue (last year)$37.3B
Annual profit (last year)$5.2B
Net profit margin12.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts


Search for Jobs